Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma

Annals of Oncology

Volumn 10, Issue 7, 1999, Pages 803-807

  Maneo, A ^b   Landoni, F ^c   Cormio, G ^c   Colombo, A ^a   Placa, F ^a   Pellegrino, A ^c   Mangioni, C ^c  

^a Ist Sci Biomediche Osp S G   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c NONE

Author keywords

5 fluorouracil; Carboplatin; Chemoradiotherapy; Recurrent cervical carcinoma

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYDRONEPHROSIS; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION INJURY; RECURRENT CANCER; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0032809601     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008356010556     Document Type: Article

References (20)

1. Rutledge FN, Smith JP, Wharton JT et al. Pelvic exenteration: Analysis of 269 patients. Am J Obstet Gynecol 1977; 129: 881-92.
2. Shingleton HM, Soong SJ, Gelder MS et al. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989; 73: 1027-34.
3. Ciatto S, Pirtoli L, Cionini L. Radiotherapy for postoperative failures of carcinoma of the cervix uteri. Surg Gynecol Obstet 1980; 151: 621-5.
4. Landoni F, Maneo A, Zanetta G et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996; 61: 321-7.
5. Thomas GJ, Dembo AJ, Fyles A et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990; 38: 446-51.
6. Schaake-Konig C, van der Bogaert W, Dalesio O et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326: 524-30.
7. Ajani JA. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus. Chest 1998; 113 (Suppll): 112-9.
8. Cummings BJ, Keane TJ, OSullivan B et al. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21: 1115-25.
9. Adelstein DJ. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol 1998; 10: 213-8.
10. Shipley WU, Prout GR, Einstein AB et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 1987; 258: 932-5.
11. Thomas GJ, Dembo AJ, Myhr T et al. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 1993; 3: 193-8.
12. Karlan BY, Chamorro T, Fowler JM et al. Concurrent interstitial radiotherapy and infusional chemotherapy for recurrent gynecologic malignancies. Int J Gynecol Cancer 1993; 3: 304-10.
13. Barber HRK, O'Neil WH. Recurrent cervical cancer after treatment by primary surgical program. Obstet Gynecol 1971; 37: 165-72.
14. Deutsch M, Parsons JA. Radiotherapy for carcinoma of the cervix recurrent after surgery. Cancer 1974; 34: 2051-5.
15. Krebs HR, Helmkamp F, Sevin BU et al. Recurrent cancer of the cervix following radical hysterectomy and pelvic lymph node dissection. Obstet Gynecol 1982; 59: 422-7.
16. Chung CK, Nahhas WA, Stryker JA et al. Treatment outcome of recurrent cervical cancer. J Surg Oncol 1983; 24: 5-10.
17. Vermerken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynecol Oncol 1993; 3: 129-42.
18. Byfield JE. 5-Fluorouracil radiation sensitization. Invest New Drugs 1989; 7: 111-6.
19. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 1989; 16: 31-43.
20. Hockel M, Schlenger K, Hamm H et al. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 1996; 77: 1918-33.